Medacta Group SA

2022 Full Year Unaudited Top-Line Figures release / Today's call at 4:00pm CET - Seite 3

Our Knee offerings reached Euro 164.5 million, with an increase of 18.4% on a constant currency basis, thanks to the continuous customer acquisition on Kinematic Alignment, Efficiency single-use instruments, GMK Sphere platform and related MySolution technologies.

The Extremities business line reported an increase in revenue of 38.8% on a constant currency basis to Euro 27.5 million; the growth was driven by the acquisition of new customers through the completeness of the Medacta Shoulder System, supported by MyShoulder and NextAR MySolution technologies.

Revenue from our Spine offering increased by 19.2% on a constant currency basis to Euro 41.5 million, driven by the expansion of MIS Platform and MySpine offering and NextAR Spine in the second semester.

Below we report the FY 2022 sales break-down by product line:

(Million Euro)	FY 2022 (€M)	FY 2021 (€M)	Reported Growth (%)	Constant Currency Growth (%)
Hip	203.6	179.3	13.6%	9.2%
Knee	164.5	131.1	25.5%	18.4%
Extremities*	27.5	19.0	45.0%	38.8%
Spine	41.5	33.8	22.9%	19.2%
TOTAL	437.1	363.1	20.4%	15.0%
* Extremities include Shoulder and Sports Med revenues